BROADCASTS.com

How does cost, potency, and bleeding risk affect which antiplatelet you choose P2Y12 inhibitors? How long after starting, do you feel comfortable stopping DAPT on a patient? How do you manage DAPT in patients who need anticoagulation?\nShow notes, Transcript and References: https://www.coreimpodcast.com/2021/04/07/5-pearls-on-dual\u2026platelet-therapy/ (https://www.coreimpodcast.com/2021/04/07/5-pearls-on-dual-antiplatelet-therapy/)\nJoin Our Team (https://www.coreimpodcast.com/join-us/)\n (https://www.coreimpodcast.com/2021/04/07/5-pearls-on-dual-antiplatelet-therapy/)Time stamps\n\n* 02:35 Indications \n* 08:52 Medications\n* 17:37 Duration\n* 28:23 De-escalation \n* 30:55 Anticoagulation \n\nTags: IM Core, CoreIM, anticoagulation, DAPT, acute coronary syndrome, stents, thrombosis, bleeding risk, cardiology, hospitalist, primary care\n\nFind the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840\n\nAdvertising Inquiries: https://redcircle.com/brands\n\nPrivacy & Opt-Out: https://redcircle.com/privacy